on-invasive diagnosis and treatment of neonatal jaundice in primary care
- Conditions
- icterusJaundice1001965410028920
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 5500
Babies are eligible if:
- They were born after 35 completed weeks of gestation.
- They are admitted in a participating PCBC during the study period within the
first week of life.
- They are expected to remain admitted for at least two days (so as to allow
for serial TcB measurements to take place).
- Signed informed consent (IC) is available from parent(s)
Babies are not eligible if:
- They previously received phototherapy (reliability of TcB measurement is
reduced in babies who are receiving or have received phototherapy).
- They have large congenital anomalies at the sternum or forehead.
- Parents do not have sufficient understanding of the Dutch language to be able
to comprehend the patient information sheet.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The two interventions each have their own primary outcome.<br /><br>1. TcB measurement<br /><br>The proportion of babies with severe hyperbilirubinaemia within 14 days of<br /><br>life.<br /><br>2. Application of phototherapy in the birth centres<br /><br>The proportion of babies requiring hospital admission for hyperbilirubinaemia<br /><br>treatment within 14 days of life.</p><br>
- Secondary Outcome Measures
Name Time Method